ADPKD终末期肾病患者的独特骨表型
本研究比较了518例终末期肾病患者(其中99例由ADPKD导致)的骨表型,发现ADPKD患者骨形成标志物骨碱性磷酸酶显著更低(17.4 vs 22.6 ng/mL),组织形态计量学骨形成参数也更低,且校正甲状旁腺激素、年龄和性别后关联持续存在;ADPKD患者皮质骨丰富部位骨密度更高,循环硬化蛋白水平更高(2.20 vs 1.84 ng/L)。结论认为ADPKD终末期肾病患者具有独特的骨与矿物质表型,特征为骨转换受抑、皮质骨密度保存较好和高硬化蛋白水平。
要点
- ADPKD终末期肾病患者骨形成标志物骨碱性磷酸酶显著低于非ADPKD患者。
- ADPKD患者组织形态计量学骨形成参数更低,且独立于甲状旁腺激素、年龄和性别。
- ADPKD患者皮质骨丰富部位骨密度更高,循环硬化蛋白水平更高。
核心结论
- ADPKD所致终末期肾病患者具有独特的骨与矿物质表型,表现为骨转换受抑、皮质骨密度保存较好和高硬化蛋白水平。
研究设计与样本
- 比较性研究,纳入518例终末期肾病患者,其中99例由ADPKD导致;71例有骨组织形态计量学数据,其中10例为ADPKD。
主要发现
- ADPKD患者骨碱性磷酸酶显著更低(17.4 vs 22.6 ng/mL),骨形成组织形态计量学参数也更低。
- ADPKD与骨形成参数的关联在校正甲状旁腺激素、年龄和性别后持续存在。
- ADPKD患者皮质骨丰富部位骨密度更高:桡骨中段Z评分-0.04 vs -0.14,股骨颈-0.72 vs -1.02。
- ADPKD患者循环硬化蛋白水平显著更高(2.20 vs 1.84 ng/L)。
临床怎么用
- 对ADPKD终末期肾病患者评估骨健康时,应考虑到其骨转换受抑和皮质骨密度保存较好的独特表型。
局限性
- 骨组织形态计量学数据仅 available 于71例患者,其中ADPKD仅10例,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autosomal dominant polycystic kidney disease (ADPKD) is among the most common hereditary nephropathies. Low bone turnover osteopenia has been reported in mice with conditional deletion of the PKD1 and PKD2 genes in osteoblasts, and preliminary clinical data also suggest suppressed bone turnover in patients with ADPKD. The present study compared the bone phenotype between patients with end stage renal disease (ESRD) due to ADPKD and controls with ESRD due to other causes. Laboratory parameters of bone mineral metabolism (fibroblast growth factor 23 and sclerostin), bone turnover markers (bone alkaline phosphatase, tartrate-resistant acid phosphatase 5b) and bone mineral density (BMD, by dual energy x-ray absorptiometry, DXA) were assessed in 518 patients with ESRD, including 99 with ADPKD. Bone histomorphometry data were available in 71 patients, including 10 with ADPKD. Circulating levels of bone alkaline phosphatase were significantly lower in patients with ADPKD (17.4 vs 22.6 ng/mL), as were histomorphometric parameters of bone formation. Associations between ADPKD and parameters of bone formation persisted after adjustment for classical determinants including parathyroid hormone, age, and sex. BMD was higher in skeletal sites rich in cortical bone in patients with ADPKD compared to non-ADPKD patients (Z-score midshaft radius -0.04 vs -0.14; femoral neck -0.72 vs -1.02). Circulating sclerostin levels were significantly higher in ADPKD patients (2.20 vs 1.84 ng/L). In conclusion, patients with ESRD due to ADPKD present a distinct bone and mineral phenotype, characterized by suppressed bone turnover, better preserved cortical BMD, and high sclerostin levels.
引用
- Evenepoel P, Claes K, Cavalier E, et al. A distinct bone phenotype in ADPKD patients with end-stage renal disease. Kidney Int. 2019. PMID: 30665572. doi:10.1016/j.kint.2018.09.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。